CSFにおけるモルヒン-6-グルキュロニドの潜在的鎮痛作用は,CSFにおけるモルヒン-6-グルキュロニドの潜在的鎮痛作用である.

Correction to: Dexketoprofen/tramadol 25 mg/75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy.

BMC anesthesiology·2017

European Pain Federation position paper on appropriate opioid use in chronic pain management.

European journal of pain (London, England)·2016

Dexketoprofen/tramadol 25 mg/75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy.

BMC anesthesiology·2016

Randomized clinical trial of dexketoprofen/tramadol 25 mg/75 mg in moderate-to-severe pain after total hip arthroplasty.

British journal of anaesthesia·2016

A conservative method of testing whether combination analgesics produce additive or synergistic effects using evidence from acute pain and migraine.

European journal of pain (London, England)·2012

End-to-end military pain management.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2010

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Rezafungin Versus Caspofungin in Candidaemia and Invasive Candidiasis: A Post Hoc Pooled Analysis of Phase 2 and Phase 3 Trials.

Mycoses·2026

Mechanisms and Therapeutic Targeting of the cGAS-STING Pathway in Central Nervous System Disorders.

Current neuropharmacology·2026

Pharmacological Characterization of Digera muricata Ethanolic Extract in a Rodent Model of Hepatotoxicity.

Recent advances in inflammation & allergy drug discovery·2026

Medical Use of Cannabis and Derived Cannabis Products in a Sample of Young Adults in the United States.

Substance use & addiction journal·2026

Novel Mutations in the MC2R Gene in a Patient With Familial Glucocorticoid Deficiency (FGD): A Case Report and Functional Study.

Molecular genetics & genomic medicine·2026

Vladimiria souliei Ameliorated Aspirin-Induced Gastric Mucosal Injury by Activation Nrf2 and Inhibition RIP1 Signaling Pathways.

Biological & pharmaceutical bulletin·2026

関連する実験動画

CSFにおけるモルヒン-6-グルキュロニドの潜在的鎮痛作用は,CSFにおけるモルヒン-6-グルキュロニドの潜在的鎮痛作用である.

関連する概念動画

Correction to: Dexketoprofen/tramadol 25 mg/75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy.

European Pain Federation position paper on appropriate opioid use in chronic pain management.

Dexketoprofen/tramadol 25 mg/75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy.

Randomized clinical trial of dexketoprofen/tramadol 25 mg/75 mg in moderate-to-severe pain after total hip arthroplasty.

A conservative method of testing whether combination analgesics produce additive or synergistic effects using evidence from acute pain and migraine.

End-to-end military pain management.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Rezafungin Versus Caspofungin in Candidaemia and Invasive Candidiasis: A Post Hoc Pooled Analysis of Phase 2 and Phase 3 Trials.

Mechanisms and Therapeutic Targeting of the cGAS-STING Pathway in Central Nervous System Disorders.

Pharmacological Characterization of Digera muricata Ethanolic Extract in a Rodent Model of Hepatotoxicity.

Medical Use of Cannabis and Derived Cannabis Products in a Sample of Young Adults in the United States.

Novel Mutations in the MC2R Gene in a Patient With Familial Glucocorticoid Deficiency (FGD): A Case Report and Functional Study.

Vladimiria souliei Ameliorated Aspirin-Induced Gastric Mucosal Injury by Activation Nrf2 and Inhibition RIP1 Signaling Pathways.

関連する実験動画

CSFにおけるモルヒン-6-グルキュロニドの潜在的鎮痛作用は,CSFにおけるモルヒン-6-グルキュロニドの潜在的鎮痛作用である.

関連する概念動画

関連記事